Dr Lalchandani Labs (BOM:541299) Debt-to-Equity : 0.71 (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs Debt-to-Equity?

Dr Lalchandani Labs's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₹32.00 Mil. Dr Lalchandani Labs's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₹30.95 Mil. Dr Lalchandani Labs's Total Stockholders Equity for the quarter that ended in Sep. 2023 was ₹88.34 Mil. Dr Lalchandani Labs's debt to equity for the quarter that ended in Sep. 2023 was 0.71.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Dr Lalchandani Labs's Debt-to-Equity or its related term are showing as below:

BOM:541299' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.08 Med: 0.53 Max: 14.31
Current: 0.71

During the past 11 years, the highest Debt-to-Equity Ratio of Dr Lalchandani Labs was 14.31. The lowest was 0.08. And the median was 0.53.

BOM:541299's Debt-to-Equity is ranked worse than
76.17% of 193 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs BOM:541299: 0.71

Dr Lalchandani Labs Debt-to-Equity Historical Data

The historical data trend for Dr Lalchandani Labs's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Lalchandani Labs Debt-to-Equity Chart

Dr Lalchandani Labs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

Get a 7-Day Free Trial

0.11

0.21

0.42

0.49

0.72

Dr Lalchandani Labs Semi-Annual Data
	Mar13	Mar14	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial													0.35	0.49	0.73	0.72	0.71

Competitive Comparison of Dr Lalchandani Labs's Debt-to-Equity

For the Diagnostics & Research subindustry, Dr Lalchandani Labs's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Lalchandani Labs's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Dr Lalchandani Labs's Debt-to-Equity falls into.

Dr Lalchandani Labs Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Dr Lalchandani Labs's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(30.874	+	33.174)	/	89.225
	=	0.72

Dr Lalchandani Labs's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(31.996	+	30.945)	/	88.344
	=	0.71

Dr Lalchandani Labs (BOM:541299) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Dr Lalchandani Labs Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Dr Lalchandani Labs's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Lalchandani Labs (BOM:541299) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048

Website

https://www.lalchandanipathlab.com

Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.

Dr Lalchandani Labs (BOM:541299) Headlines

No Headlines